Search Within

Zhan Yao

Formats
  1. Journal Article (23)
  2. Meeting Abstract (14)
  3. Research Letter (1)
Groups
  1. Sloan Kettering Institute Postdocs (38)
  2. Department of Medicine (36)
  3. Solid Tumor Oncology Division (36)
  4. GSK Faculty (35)
  5. Breast Medicine Service (34)
  6. Molecular Pharmacology and Chemistry Program Faculty (34)

More Groups

People
  1. Neal Rosen (34)
  2. Elisa De Stanchina (12)
  3. Rona Yaeger (12)
  4. Barry Taylor (11)
  5. David Solit (11)
  6. Omar Abdel-Wahab (10)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2020 (5)
  4. 2019 (7)
  5. 2018 (5)
  6. 2017 (5)

More Years

Publications
  1. Cancer Research (11)
  2. Cancer Discovery (5)
  3. Nature (3)
  4. European Journal of Cancer (2)
  5. Neuro-Oncology (2)
  6. Blood (1)

More Publications

Publishers
  1. American Association for Cancer Research (19)
  2. Nature Publishing Group (5)
  3. American Society of Clinical Oncology (2)
  4. Cell Press (2)
  5. Elsevier Inc. (2)
  6. Oxford University Press (2)

More Publishers

Results (38)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • V211D mutation in MEK1 causes resistance to MEK inhibitors in colon cancer
    Journal Article

    Gao, Y.; Maria, A.; Na, N.; da Cruz Paula, A.; Gorelick, A. N.; Hechtman, J. F.; Carson, J.; Lefkowitz, R. A.; Weigelt, B.; Taylor, B. S.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Modeling and targeting KIAA1549-BRAE driven CNS tumors
    Meeting Abstract

    Kannan, R.; Cook, P.; Yao, Z.; Lee, J.; Mastroleo, C.; Ogrodowski, P.; Rosen, N.; Benezra, R.; Ventura, A.
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Rare BRAF mutations in pancreatic neuroendocrine tumors may predict response to RAF and MEK inhibition
    Journal Article

    Allen, A.; Qin, A. C. R.; Raj, N.; Wang, J.; Uddin, S.; Yao, Z.; Tang, L.; Meyers, P. A.; Taylor, B. S.; Berger, M. F.; more...
    PLoS ONE (2019)

    Fulltext@MSK | Save
  • RAF inhibitor PLX8394 selectively disrupts BRAF dimers and RAS-independent BRAF-mutant-driven signaling
    Research Letter

    Yao, Z.; Gao, Y.; Su, W.; Yaeger, R.; Tao, J.; Na, N.; Zhang, Y.; Zhang, C.; Rymar, A.; Tao, A.; more...
    Nature Medicine (2019)

    Fulltext@MSK | Save
  • A secondary mutation in BRAF confers resistance to RAF inhibition in a BRAF V600E-mutant brain tumor
    Meeting Abstract

    Wang, J.; Yao, Z.; Jonsson, P.; Allen, A.; Qin, A. C. R.; Uddin, S.; Dunkel, I. J.; Petriccione, M.; Manova, K.; Haque, S.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Intermittent treatment with MEK inhibitors in patients with oncogenic RAF-driven tumors: A potential strategy to manage toxicity and maintain efficacy
    Journal Article

    Yaeger, R.; Yao, Z.; Chapman, P. B.
    JCO Precision Oncology (2018)

    Fulltext@MSK | Save
  • PLX8394 selectively disrupts BRAF-dimers and RAS-independent BRAF mutant-driven signaling
    Meeting Abstract

    Yao, Z.; Gao, Y.; Su, W.; Yaeger, R.; Na, N.; Zhang, Y.; Zhang, C.; Rymar, A.; Tao, A.; Torres, N.; more...
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • A secondary mutation in BRAF confers resistance to RAF inhibition in a BRAF(V600E)-mutant brain tumor
    Journal Article

    Wang, J.; Yao, Z.; Jonsson, P.; Allen, A. N.; Qin, A. C. R.; Uddin, S.; Dunkel, I. J.; Petriccione, M.; Manova, K.; Haque, S.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Allele-specific mechanisms of activation of mek1 mutants determine their properties
    Journal Article

    Gao, Y.; Chang, M. T.; McKay, D.; Na, N.; Zhou, B.; Yaeger, R.; Torres, N. M.; Muniz, K.; Drosten, M.; Barbacid, M.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Mechanisms of acquired resistance to BRAF V600E inhibition in colon cancers converge on RAF dimerization and are sensitive to its inhibition
    Journal Article

    Yaeger, R.; Yao, Z.; Hyman, D. M.; Hechtman, J. F.; Vakiani, E.; Zhao, H.; Su, W.; Wang, L.; Joelson, A.; Cercek, A.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save